Sandeep S. Dave, MD
MiRNA in NHL
Leo I. Gordon, MD
Purine Analogs in Indolent Lymphoma: Pro Vs. Con
Brad Kahl, MD
Management of Very High Risk DLBCL: Is There Still a Role for Front-Line Transplant
Philippe Solal-Celigny, MD, PhD
Keynote Lecture: Prognosis in Follicular Lymphoma in the Modern Era
Page last update: November 12, 2011
